Black Widow Antivenin (Latrodectus Mactans)

[03 February 2016]

Products Affected - Description

All presentations are currently available

Reason for the Shortage

Merck had low inventory of Antivenin Latrodectus Mactans.

Available Products

Antivenin Lactrodectus Mactans (Black Widow Spider Antivenin) powder for solution for injection, Merck
6000 units, vial, 1 count (NDC 00006-5424-02)

Estimated Resupply Dates

Merck is allowing 2 doses per site.

Related Shortages


February 3, 2016; December 8, September 2, June 11, April 13, February 16, 2015; December 12, October 13, August 7 and 6, June 3, March 12, 2014; December 16, October 2, July 18, May 14, March 20, January 28, 2013; November 7, October 1, August 8, May 4, March 7, January 10, 2012; November 4, September 2, July 26, June 2, April 26, March 16, February 2, 2011; December 29, August 5, May 24, March 17, January 25, 2010; December 7, October 20 and 19, September 2, May 15, April 20, March 5, 2009, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing